FHA
INO icon

Flagship Harbor Advisors’s Inovio Pharmaceuticals INO Stock Holding History

Flagship Harbor Advisors’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-31
Closed -$4K – 1102
2020
Q3 		$4K Buy
31
+26
+520% +$5.42K ﹤0.01% 1577
2020
Q2 		$1K Sell
5
-39
-89% -$6.26K ﹤0.01% 1912
2020
Q1 		$4K Buy
44
+42
+2,100% +$2.59K ﹤0.01% 1466
2019
Q4 		$0 Hold
2
– – ﹤0.01% 1914
2019
Q3 		$0 Sell
2
-42
-95% -$1.28K ﹤0.01% 1902
2019
Q2 		$1K Buy
44
+42
+2,100% +$1.67K ﹤0.01% 1774
2019
Q1 		$0 Hold
2
– – ﹤0.01% 1892
2018
Q4 		$0 Hold
2
– – ﹤0.01% 1970
2018
Q3 		$0 Hold
2
– – ﹤0.01% 2101
2018
Q2 		$0 Buy
+2
New +$110 ﹤0.01% 2044

Other funds holding INO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Flagship Harbor Advisors's INO Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Inovio Pharmaceuticals (INO) in Q4 2020, closing a stake of 31 shares — an estimated $4K sold.

Flagship Harbor Advisors first reported a position in INO in Q2 2018 and held it in 10 quarters. The position peaked at $4K in Q3 2020. 227 funds tracked by Wall St. Rank hold INO as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Inovio Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 31 Inovio Pharmaceuticals shares in Q4 2020, an estimated $4K.
  • Flagship Harbor Advisors first reported a position in Inovio Pharmaceuticals in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Inovio Pharmaceuticals position peaked at $4K in Q3 2020.
  • 227 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.